trazodone has been researched along with Pulsatile Tinnitus in 2 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antidepressant drugs have been used to treat tinnitus in patients with and without depressive symptoms." | 2.48 | Antidepressants for patients with tinnitus. ( Baldo, P; Cecco, S; Doree, C; McFerran, D; Molin, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morinaga, Y | 1 |
| Nii, K | 1 |
| Hanada, H | 1 |
| Takemura, Y | 1 |
| Sakamoto, K | 1 |
| Inoue, R | 1 |
| Mitsutake, T | 1 |
| Tsugawa, J | 1 |
| Kurihara, K | 1 |
| Tateishi, Y | 1 |
| Higashi, T | 1 |
| Baldo, P | 1 |
| Doree, C | 1 |
| Molin, P | 1 |
| McFerran, D | 1 |
| Cecco, S | 1 |
1 review available for trazodone and Pulsatile Tinnitus
| Article | Year |
|---|---|
Antidepressants for patients with tinnitus.
Topics: Amitriptyline; Antidepressive Agents; Depression; Humans; Nortriptyline; Paroxetine; Randomized Cont | 2012 |
1 other study available for trazodone and Pulsatile Tinnitus
| Article | Year |
|---|---|
Clinical features of Barré-Lièou syndrome and efficacy of trazodone for its treatment: A retrospective single center study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Autonomic Nervous System; | 2021 |